Sex Differences in Chronic Kidney Disease (NCT03771703) | Clinical Trial Compass
UnknownNot Applicable
Sex Differences in Chronic Kidney Disease
Austria1,100 participantsStarted 2018-12-02
Plain-language summary
This study aims to describe sex specific differences of the hemodialysis population in Austria, to quantify sex specific differences in treatment and outcomes in hospitalized patients with chronic kidney disease and to examine decision making by doctors and patients with regards to hemodialysis initiation.
To adequately serve the needs of these research questions, the study is divided into 3 parts (sub-studies).
1. Description and analysis of sex-specific differences in renal replacement therapy in Austria.
2. Description and analysis of the competing risks of death versus renal replacement therapy initiation in the chronic kidney disease population by sex.
3. Analysis of sex differences in renal replacement therapy initiation decisions, emphasizing patient perception and socio-economic differences.
Who can participate
Age range
18 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Austrian Dialysis Registry Patient or outpatient
* Criteria for participation in the survey will be (i) a diagnosis of CKD (eGFR \<60 mL/min/1.73 m2) \[50% \<15\]) and (ii) appropriate language skills to fill in a survey.
Exclusion Criteria:
* Not an Austrian Dialysis Registry Patient or not an outpatient
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Sex-specific mortality among incident patients undergoing hemodialysis
Timeframe: Through study completion, the expected average follow-up being 4 years.